What is the address of FARMA - IMMO?

The registered office of FARMA - IMMO is located at Parkstraat 2, 8730 Beernem.

Is FARMA - IMMO still active?

Yes. According to the CBE (29 October 2026) FARMA - IMMO is active, legal situation “Normale toestand”, started on 22 May 1987.

Is FARMA - IMMO registered on Peppol?

Yes, FARMA - IMMO is registered on the Peppol network with ID 0208:0431280905.

What is the enterprise number of FARMA - IMMO?

The enterprise number of FARMA - IMMO is BE0431280905.

When was FARMA - IMMO founded?

FARMA - IMMO was founded on 22 May 1987.

Who are the directors of FARMA - IMMO?

According to the 2025 annual accounts, the directors of FARMA - IMMO are: Wisli Invest NV, Ward Cecat GCV.

Is FARMA - IMMO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 May 1987; 4 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did FARMA - IMMO make in 2025?

FARMA - IMMO posted a profit after taxes of € 1,141,755 in financial year 2025.

What is the revenue of FARMA - IMMO?

As a small company, FARMA - IMMO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 2,275,548.

FARMA - IMMO (Public Limited) - Beernem - BE0431280905

Q: What does FARMA - IMMO do?

FARMA - IMMO is registered with the CBE as active in: Diverse ondersteunende activiteiten ten behoeve van voorzieningen. Public Limited, started on 22 May 1987, 1 establishment.

Dossier FARMA - IMMO, printed on 29 October 2026 from databakkes.be/en/0431280905/farma-immo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 22 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

FARMA - IMMO from Beernem, company number BE0431280905, closed financial year 2025 with a result of € 1.1 million after tax. For that financial year FARMA - IMMO recorded a gross margin of € 2.3 million and equity of € 7.3 million. Compared with financial year 2024, the result moved from € 61,768 to € 1.1 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 27, 2026.

What it is worth Growing

€ 7.3 million

▲ 18% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 1.1 million

▲ € 1.1 million vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 521,718

▲ 93% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 5.6 million.

People and assets in 2025

Vehicles and equipment

€ 15,007

▲ € 14,688 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 479,166

▼ 21% vs 2024

€ 125,000 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 47,470

▲ € 42,161 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 851,431 Gross margin 2022: € 851,431 First fiscal year in the series	€ 1,109,571 Gross margin 2023: € 1,109,571 ▲ 30% vs 2022 (€ 851,431) Favourable step	€ 828,192 Gross margin 2024: € 828,192 ▼ 25% vs 2023 (€ 1,109,571) Unfavourable step	€ 2,275,548 Gross margin 2025: € 2,275,548 ▲ 175% vs 2024 (€ 828,192) Favourable step	▲ 175%
Profit after taxes	€ 257,719 Profit after taxes 2022: € 257,719 First fiscal year in the series	€ 74,532 Profit after taxes 2023: € 74,532 ▼ 71% vs 2022 (€ 257,719) Unfavourable step	€ 61,768 Profit after taxes 2024: € 61,768 ▼ 17% vs 2023 (€ 74,532) Unfavourable step	€ 1,141,755 Profit after taxes 2025: € 1,141,755 ▲ € 1.1 million vs 2024 (€ 61,768) Favourable step	▲ € 1.1 million
Equity	€ 6,065,010 Equity 2022: € 6,065,010 First fiscal year in the series	€ 6,134,542 Equity 2023: € 6,134,542 ▲ 1% vs 2022 (€ 6,065,010) Favourable step	€ 6,191,310 Equity 2024: € 6,191,310 ▲ 1% vs 2023 (€ 6,134,542) Favourable step	€ 7,333,065 Equity 2025: € 7,333,065 ▲ 18% vs 2024 (€ 6,191,310) Favourable step	▲ 18%
Total debts	€ 4,878,054 Total debts 2022: € 4,878,054 First fiscal year in the series	€ 4,573,927 Total debts 2023: € 4,573,927 ▼ 6% vs 2022 (€ 4,878,054) Favourable step	€ 4,053,816 Total debts 2024: € 4,053,816 ▼ 11% vs 2023 (€ 4,573,927) Favourable step	€ 2,942,244 Total debts 2025: € 2,942,244 ▼ 27% vs 2024 (€ 4,053,816) Favourable step	▼ 27%
Cash	€ 61,308 Cash 2022: € 61,308 First fiscal year in the series	€ 372,613 Cash 2023: € 372,613 ▲ € 311,305 vs 2022 (€ 61,308) Favourable step	€ 269,681 Cash 2024: € 269,681 ▼ 28% vs 2023 (€ 372,613) Unfavourable step	€ 521,718 Cash 2025: € 521,718 ▲ 93% vs 2024 (€ 269,681) Favourable step	▲ 93%
Land & buildings	€ 11,503,859 Land & buildings 2022: € 11,503,859 First fiscal year in the series	€ 11,047,129 Land & buildings 2023: € 11,047,129 ▼ 4% vs 2022 (€ 11,503,859) Unchanged	€ 10,664,236 Land & buildings 2024: € 10,664,236 ▼ 3% vs 2023 (€ 11,047,129) Unchanged	€ 10,281,903 Land & buildings 2025: € 10,281,903 ▼ 4% vs 2024 (€ 10,664,236) Unchanged	▼ 4%
Retained profit	€ 4,354,518 Retained profit 2022: € 4,354,518 First fiscal year in the series	€ 4,424,050 Retained profit 2023: € 4,424,050 ▲ 2% vs 2022 (€ 4,354,518) Favourable step	€ 4,480,818 Retained profit 2024: € 4,480,818 ▲ 1% vs 2023 (€ 4,424,050) Favourable step	€ 5,622,573 Retained profit 2025: € 5,622,573 ▲ 25% vs 2024 (€ 4,480,818) Favourable step	▲ 25%
Dividend	€ 90,000 Dividend 2022: € 90,000 First fiscal year in the series	€ 5,000 Dividend 2023: € 5,000 ▼ 94% vs 2022 (€ 90,000) Unchanged	€ 5,000 Dividend 2024: € 5,000 Unchanged (€ 5,000) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 5,000) Unchanged	▼ 100%
Bank debt	€ 854,167 Bank debt 2022: € 854,167 First fiscal year in the series	€ 729,167 Bank debt 2023: € 729,167 ▼ 15% vs 2022 (€ 854,167) Favourable step	€ 604,166 Bank debt 2024: € 604,166 ▼ 17% vs 2023 (€ 729,167) Favourable step	€ 479,166 Bank debt 2025: € 479,166 ▼ 21% vs 2024 (€ 604,166) Favourable step	▼ 21%
Balance sheet total	€ 11,731,571 Balance sheet total 2022: € 11,731,571 First fiscal year in the series	€ 11,493,387 Balance sheet total 2023: € 11,493,387 ▼ 2% vs 2022 (€ 11,731,571) Unchanged	€ 10,992,379 Balance sheet total 2024: € 10,992,379 ▼ 4% vs 2023 (€ 11,493,387) Unchanged	€ 11,084,410 Balance sheet total 2025: € 11,084,410 ▲ 1% vs 2024 (€ 10,992,379) Unchanged	▲ 1%

Key figures of FARMA - IMMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to FARMA - IMMO?

What happened at FARMA - IMMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2026 Wisli Invest NV stepped down as director. NBB
Feb 27, 2026 New annual accounts for financial year 2025: profit of € 1.1 million (▲ € 1.1 million vs 2024). filed late Source: NBB ↗
2025 Ward Cecat GCV stepped down as director. NBB
2020 Wisli Invest NV became a director. NBB
2020 Ward Cecat GCV became a director. NBB
Jul 23, 1987 New establishment in Beernem. KBO
May 22, 1987 Start of the company according to the CBE. KBO

In short

From € 257,719 profit in 2022 to € 1.1 million profit in 2025.

Paid € 472,140 in corporate taxes since 2022.

Best year ever: 2025, with € 1.1 million profit.

Paid out € 100,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

WISLI INVEST 100%

APOTHEEK DESSEIN 15.1%

The stake of WISLI INVEST, APOTHEEK DESSEIN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

FARMA - IMMO

HIMCO NV 25%

The shares are held by WISLI INVEST (100%) and APOTHEEK DESSEIN (15.1%). It owns 25% of HIMCO NV itself.

Directors

According to the 2025 annual accounts

Wisli Invest NV

Managing director · represented by Lieven De Marez

Also active at: APOTHEEK DESSEIN

since 2020 · until 2026

Ward Cecat GCV

Director · represented by Ward Cecat

since 2020 · until 2025

Shareholders

WISLI INVEST

100%

APOTHEEK DESSEIN

15.1%

Participations

HIMCO NV

25%

Establishments

Establishment units

Physical locations of this company

Registered office

Parkstraat 2

8730 Beernem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.

All companies at this address →

APOTHEEK DESSEIN same network

€ 35.7 million revenue · 2025

VETRIA

€ 16.1 million revenue · 2025

XLENT-IMMO

€ -350 gross margin · 2025

SANIDUS

€ -4,947 gross margin · 2025

WISLI INVEST same network

€ 555,249 revenue · 2025

+2 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0431.280.905

VAT number

BE 0431.280.905

Registered office

Parkstraat 2, 8730 Beernem

Names & denominations

FARMA - IMMO

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

22 May 1987

Peppol

Active · Active since 16 Mar 2026

Activities · NACE

Diverse ondersteunende activiteiten ten behoeve van voorzieningen

Beheer van overig onroerend goed

View on CBE Public ↗ Annual accounts (NBB) ↗

FARMA - IMMO

Warning lights

Financials

What happened to FARMA - IMMO?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions